In a renal cell adenocarcinoma study, IRF9 knockdown was shown to increase tumor formation in a xenograft model, whereas the overexpression of both IRF9 and STAT2 reduced tumor growth [31]. Here, IRF9 is linked to renal cell adenocarcinoma.